NeuPath Health Inc. · TSXV:NPTH
NeuPath Health — Investor Presentation (April 2021)
20 slides from NeuPath Health's investor presentation, April 2021
Slide 1: Corporate Presentation April 2021
CORPORATE PRESENTATION APRIL 2021 TSXV: NPTH www.neupath.com
Slide 2: Legal Disclaimer
Legal Disclaimer Certain statements contained in this Presentation may constitute forward-looking information under the meaning of applicable securities laws, which are based on the opinions, estimates and assumptions of the NeuPath’s management and are subject to a variety of risks, uncertainties a
Slide 3: Legal Disclaimer – non-IFRS Measures
Legal Disclaimer – non-IFRS Measures Non-IFRS Measures This presentation contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as
Slide 4: NeuPath Health overview
NeuPath Health overview $57M NeuPath owns and operates a network of 13 140,000+ Annual clinics across Canada that 13 wholly- annual Revenue Run deliver category-leading owned clinics patient visits Rate1 treatment for chronic pain, as well as spinal injuries, sports related injuries, and concussions
Slide 5: Investment highlights
Investment highlights • Largest pain & musculoskeletal clinic network in Canada • 13 wholly owned clinics plus minority interests in 2 more clinics • Blended care model, combining in-person & virtual visits • Proprietary remote pain management tech & virtual visits comprise 9% of total visits • Annu
Slide 6: Positive EBITDA & access to capital = platform for growth
Positive EBITDA & access to capital = platform for growth aa aa aa aa aa May 2017 Feb 2018 Jul 2020 Oct 2020 Nov 2020 Feb 2021 Mar 2021 • NeuPath • Acquired • Started • Began work • Closed • Expanded to • Reported 8th was founded group of 3 trading on with Pivot to oversubscribed Alberta consecutive
Slide 7: $37 billion+ total addressable market
$37 billion+ total addressable market • NeuPath is focused on treating musculoskeletal pain and related conditions • Chronic Pain • $15-$17 billion annual direct health care costs in Canada2 • Sport Medicine • Injuries cost public health system $1.5 billion annually3 • Concussions • $1 billion annua
Slide 8: Research, Technology, Interdisciplinary Care
Research Technology Interdisciplinary Care • Evidence-based care is our • Technology to enhance care • Collaborative care model starting point • Improve outcomes • Roster includes: • Leverage our wholly-owned • Improve scalability and • Physiatrists Contract Research reach • Neurologists Organizatio
Slide 9: Comprehensive, holistic service offering
Comprehensive, holistic service offering • Comprehensive assessments • Ultrasound guided injections 70% to • Physiotherapy • Electromyography No physician physician & • Psychotherapy • Non-imaging guided payment or not 30% to • Chronic Pain Self- injections monetized company Management Program • Med
Slide 10: Remote pain management technology
Remote pain management technology • Musculoskeletal conditions are the biggest cost driver in organizations’ health care spending in Canada & US • Chronic pain is the leading cause of disability & disease burden globally • NeuPath is developing proprietary digital health tech targeting musculoskelet
Slide 11: Remote pain management technology
Remote pain management technology • Personalized education on the impact of sleep, diet, exercise, medication, and other contributing factors • Access to coaching • Self-management tools • Enhanced tracking and measurement of changes in patient function • Improved communication with care providers •
Slide 12: Growth strategy
Growth strategy • Increase capacity utilization from 53% in existing clinics • Add services, onboard new doctors, and improve patient throughput • Continue to build out national network by acquiring and building new clinics • National network is critical to rollout of employer health program • Relea
Slide 13: Financial Performance and Capitalization
Financial Performance and Capitalization Growing Adjusted EBITDA Margins HealthPointe Acquisition Impact through the Pandemic • $9M - 2020 revenue • 6% - 2020 Adjusted EBITDA margin • 64% - Capacity Utilization during COVID Capitalization • 45.1M - Shares Outstanding • 70.9M – Fully Diluted • 11.4%
Slide 14: Comparable Companies
Comparable Companies Share Market Cap EV CAGR - Revenue EV / Sales Company Price (C$mm, as of 2021-04-19) 1 Year 2 Year 3 Year CY19 CY20 CY21e 1Life Healthcare (NASDAQ: ONEM) US$ 40.92 6,884.9 6,511.1 53.1% 30.8% n.d. 18.8x 13.7x 10.8x WELL Health (TSX: WELL) C$ 7.16 1,391.5 1,510.4 76.5% 118.1% n.m
Slide 15: Experienced Leadership Team
Experienced Leadership Team • Joined in July 2018 • Former CEO of VroomHealth Grant Connelly • Former CFO of Appletree Medical Group that operated over 30 medical clinics Chief Executive Officer • Over $200M in M&A transactions • MBA – Schulich School of Business at York • Joined in April 2019 • CPA
Slide 16: Board of Directors
Board of Directors Dianne Carmichael, Chair Jolyon Burton • Former President, Best Doctors Inc. • Co-founder of Bloom Burton & Co., providing capital raising, • Former President, Payer Markets at McKesson M&A advisory, equity research, business strategy & scientific • Former President, UHN Solutions
Slide 17: Investment highlights
Investment highlights • Largest pain & musculoskeletal clinic network in Canada • 13 wholly owned clinics plus minority interests in 2 more clinics • Blended care model, combining in-person & virtual visits • Proprietary remote pain management tech & virtual visits comprise 9% of total visits • Annu
Slide 18: Thank You
NeuPath Health Grant Connelly, CEO [email protected] Thank You Stephen Lemieux, CFO [email protected] [email protected] 18
Slide 19: Corporate Presentation
CORPORATE PRESENTATION APRIL 2021 TSXV: NPTH www.neupath.com
Slide 20: Adjusted EBITDA
Adjusted EBITDA Non-IFRS Measures EBITDA refers to net income (loss) determined in accordance with IFRS, before depreciation and amortization, net interest expense (income) and income tax expense (recovery). The Company defines adjusted EBITDA as net income from continuing operations before net inte